Advertisement

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

Fabio Efficace, Michele Baccarani, Massimo Breccia, Giuliana Alimena, Gianantonio Rosti, Francesco Cottone, Giorgio Lambertenghi Deliliers, Claudia Baratè, Antonella Russo Rossi, Giuseppe Fioritoni, Luigia Luciano, Diamante Turri, Bruno Martino, Francesco Di Raimondo, Melissa Dabusti, Micaela Bergamaschi, Pietro Leoni, Maria Pina Simula, Luciano Levato, Stefano Ulisciani, Dino Veneri, Simona Sica, Alessandro Rambaldi, Marco Vignetti, Franco Mandelli and for GIMEMA

Article Information

Citation 
vol. 118 no. 17 4554-4560
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted April 8, 2011
  • Accepted June 20, 2011
  • Published online October 27, 2011.

Article Versions


Contributors 
  • Fabio Efficace, 1Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy;
  • Michele Baccarani, 2Department of Hematology-Oncology, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy;
  • Massimo Breccia, 3Department of Biotechnologies and Hematology, University of Rome Sapienza, Rome, Italy;
  • Giuliana Alimena, 3Department of Biotechnologies and Hematology, University of Rome Sapienza, Rome, Italy;
  • Gianantonio Rosti, 2Department of Hematology-Oncology, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy;
  • Francesco Cottone, 1Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy;
  • Giorgio Lambertenghi Deliliers, 4Department of Hematology, Istituto Di Recovero e Cura a Carattere Scientifico Ospedale Maggiore Policlinico, Milan, Italy;
  • Claudia Baratè, 5Department of Hematology, University of Pisa, Pisa, Italy;
  • Antonella Russo Rossi, 6Department of Hematology, University of Bari, Bari, Italy;
  • Giuseppe Fioritoni, 7Hematology, Local Health Unit of Pescara, Pescara, Italy;
  • Luigia Luciano, 8Department of Hematology, University of Naples Federico II, Naples, Italy;
  • Diamante Turri, 9Department of Hematology, Hospital Cervello, Palermo, Italy;
  • Bruno Martino, 10Department of Hematology, Ospedali Riuniti, Reggio Calabria, Italy;
  • Francesco Di Raimondo, 11Department of Hematology, Hospital Ferrarotto, Catania, Italy;
  • Melissa Dabusti, 12Department of Hematology, Arcispedale Sant'Anna, Ferrara, Italy;
  • Micaela Bergamaschi, 13Department of Hematology, University of Genova, Clinica Ematologica S. Martino Hospital, Genova, Italy;
  • Pietro Leoni, 14Department of Hematology, Hospital Torrette, Ancona, Italy;
  • Maria Pina Simula, 15Ospedale Oncologico di Riferimento Regionale Armando Busiinco, Struttura Complessa di Ematologia e Centro Trapianti, Cagliari, Italy;
  • Luciano Levato, 16Department of Hematology, Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy;
  • Stefano Ulisciani, 17Department of Hematology, University of Turin, Orbassano, Italy;
  • Dino Veneri, 18Department of Hematology, University of Verona, Verona, Italy;
  • Simona Sica, 19Department of Hematology, University of Rome Cattolica S. Cuore, Rome, Italy; and
  • Alessandro Rambaldi, 20Department of Hematology, Ospedali Riuniti di Bergamo, Bergamo, Italy
  • Marco Vignetti, 1Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy;
  • Franco Mandelli, 1Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output